Newcastle disease virus (NDV or AOaV-1) is an avian paramyxovirus that typically causes only mild, self-limiting disease in humans. Here, we report fatal neuroinvasive AOaV-1 infection in a patient with multiple myeloma receiving maintenance therapy with teclistamab, daratumumab, and lenalidomide following frontline te...
Christina Krueger, C. Schaefers, T. Guenther et al.· Acta Neuropathologica· 0 citations
(GPRC5D) is a leading immunotherapy target in multiple myeloma (MM), with diverse GPRC5D-targeting agents — including T-cell engagers (TCE), antibody – drug conjugates
Ricardo Ahrens, K. Ahrens, Maximilian Al-Bazaz et al.· Blood Cancer Journal· 0 citations
Biparatopic targeting of CD38 using CD38-STARs represents a promising strategy for the treatment of MM, including the rare cases in which daratumumab fails to bind due to CD38 mutations.
H. Risch, A. J. Gebhardt, Niklas Hagen et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.